The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Please provide your email address to receive an email when new articles are posted on . Pregnant women with type 1 diabetes had a lower time below range with the MiniMed 780 system vs. standard of ...

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had a higher time in range with fully closed-loop insulin delivery than with ...

The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...